Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P15088 (
mast cell
)
14,925
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phospholipase A2 is ubiquitous in nature, with the highest concentrations occurring in pancreatic juice and in the venom of snakes. Local oedema formation is a common feature of the effects caused by snakebite, and indicates an increase in vascular permeability that could be produced by lipid mediators such as lysophospholipids, eicosanoids or PAF release by the enzymatic activity of PLA2. Desalted porcine pancreatic PLA2 exhibited strong oedema-inducing activity in a similar form to PLA2 venom from Naja naja or Crotalus durissus terrificus. Furthermore, all three
PLA2S
caused the release of histamine from rat peritoneal mast cells. However, non-desalted pancreatic PLA2 that was presented as an ammonium sulphate suspension (3.2 M) had no proinflammatory activity and clearly did not release histamine in vitro. When the enzymatic activity of PLA2 on
mast cell
membranes prelabelled with [3H] arachidonic acid was determined, a relationship between the enzymatic activity and
mast cell
degranulation and the minimum oedema dose was observed. However, non-desalted porcine pancreatic PLA2 had the same enzymatic activity as the desalted enzyme but had little proinflammatory activity. This may be due to decreased histamine secretion caused by the presence of ammonium sulphate. Our study supports the idea that the proinflammatory activity of extracellular phospholipases could depend on their ability to cause
mast cell
degranulation. Moreover, the biological effects of PLA2 are correlated with the specific activities of the enzymes.
...
PMID:Oedema formation and degranulation of mast cells by phospholipase A2 purified from porcine pancreas and snake venoms. 821 47